The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

This factor helps explain why the device failed to match other commercially approved devices in the IDE trial.

Citing a low hemorrhage rate and other issues, one expert says the results should be replicated before changing practice.

The TCTMD news team discuss their favorite moments of the month. Today's special guest is Morton Kern.

Researchers used PET/MRI to detect otherwise invisible inflammation. Less clear is how this might influence patient care.

The free risk calculator can be incorporated into existing spreadsheets of patient data for use in heart team discussions.

A sex gap seen in quality of life deserves further scrutiny, but the DISCHARGE trial data are still reassuring, says Maros ...

The higher stroke risk appears to accrue over time, and researchers say more work is needed to better understand why.

The observed treatment rates, which “absolutely can go higher,” wouldn’t be acceptable for serious cancers, Stephen Greene ...

The findings from the Women’s Health Initiative are in line with recent guidelines for the primary prevention of stroke.

Tailoring the number of consults based on HF severity, which can be assessed pragmatically, could pay dividends, say ...

As patients experience all events, not just the first, researchers should consider adjusting their trials to capture all ...